Advanced Medical Solutions Group (LON:AMS) Posts Earnings Results

Advanced Medical Solutions Group (LON:AMS) announced its quarterly earnings results on Wednesday. The company reported GBX 6.39 earnings per share for the quarter, Digital Look Earnings reports. Advanced Medical Solutions Group had a return on equity of 1.44% and a net margin of 1.58%.

Advanced Medical Solutions Group Price Performance

LON:AMS traded up GBX 0.50 during mid-day trading on Friday, hitting GBX 282. 1,876,071 shares of the stock traded hands, compared to its average volume of 3,263,945. The business’s 50-day moving average price is GBX 280.78 and its 200 day moving average price is GBX 245.54. The company has a quick ratio of 4.58, a current ratio of 2.94 and a debt-to-equity ratio of 33.60. The company has a market cap of £613.65 million, a PE ratio of 62.39, a price-to-earnings-growth ratio of 5.00 and a beta of 0.70. Advanced Medical Solutions Group has a 12-month low of GBX 187 and a 12-month high of GBX 284.50.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a GBX 275 price objective on shares of Advanced Medical Solutions Group in a report on Friday, June 26th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of GBX 278.33.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.